Canaan Partners Portfolio 2026

37 companies backed by Canaan Partners, including AttoTude, Draig Therapeutics, Neofin. Each links to its full verified cap-table syndicate.

Canaan Partners accounts for 54 tracked companies with verified cap-table data, 54 of which disclose round sizes totalling $7.9B. The median disclosed raise is $87M, and the largest is Snyk at $1.2B, ahead of Ursa Major Technologies ($506M) and Ursa Major ($506M).

The names that recur most often on these portfolio cap tables are Canaan Partners (54 companies), Coatue (4 companies), Accel (3 companies), GV (3 companies), Kaiser Permanente Ventures (3 companies), Connecticut Innovations (3 companies). By latest disclosed round, the market skews Series B (13), Series A (10), Series C (9), Series D (8).

Best funded Canaan Partners companies

  1. Snyk — $1.2B (latest: Series F)
  2. Ursa Major Technologies — $506M (latest: Series E)
  3. Ursa Major — $506M (latest: Series E)
  4. Turo — $468M (latest: Series D)
  5. Field AI — $400M (latest: Series B)
  6. EndoGastric Solutions — $374M (latest: Series I)
  7. Catalym — $319M (latest: Series D)
  8. Unchained Labs — $250M (latest: Growth)
  9. Alterome Therapeutics — $231M (latest: Series A)
  10. Halda Therapeutics — $202M (latest: Series B)
  11. Kepler Communications — $200M (latest: Series C)
  12. Glooko — $171M (latest: Series F)
  13. OncoResponse — $150M (latest: Series D)
  14. Embroker — $142M (latest: Series C)
  15. Draig Therapeutics — $140M (latest: Series A)

Canaan Partners Israel — related firms and companies (45)

Canaan Partners Israel profile · All research reports